The EMA’s safety committee established that the AstraZeneca vaccine is safe for use. The committee preliminarily investigated the reported incidents of blood clots after vaccination with the AstraZeneca vaccine and found no evidence linking the vaccine with said health issue. Today, the Ministry of Health will call upon the vaccination centres to proceed with their vaccinations. The EMA’s decision is bound to have a positive impact on public confidence in the vaccine, thus increasing people’s interest in getting vaccinated.